These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30763034)

  • 1. The drug price iceberg: more than meets the eye.
    Fendrick AM; George D
    Am J Manag Care; 2019 Feb; 25(2):57-58. PubMed ID: 30763034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the effects of drug price reduction policies on older people in Taiwan.
    Chu HL; Liu SZ; Romeis JC
    Health Serv Manage Res; 2011 Feb; 24(1):1-7. PubMed ID: 21285360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
    Wineinger NE; Zhang Y; Topol EJ
    JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?
    Sarnak DO; Squires D; Kuzmak G; Bishop S
    Issue Brief (Commonw Fund); 2017 Oct; 2017():1-14. PubMed ID: 28990747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drug prices in the US.
    Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.
    Wouters OJ; Kanavos PG; McKEE M
    Milbank Q; 2017 Sep; 95(3):554-601. PubMed ID: 28895227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending.
    Dusetzina SB; Conti RM; Yu NL; Bach PB
    JAMA Intern Med; 2017 Aug; 177(8):1185-1188. PubMed ID: 28558108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.
    Kanavos P; Ferrario A; Vandoros S; Anderson GF
    Health Aff (Millwood); 2013 Apr; 32(4):753-61. PubMed ID: 23569056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiums.
    Starner CI; Alexander GC; Bowen K; Qiu Y; Wickersham PJ; Gleason PP
    Health Aff (Millwood); 2014 Oct; 33(10):1761-9. PubMed ID: 25288420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription Drugs-List Price, Net Price, and the Rebate Caught in the Middle.
    Dusetzina SB; Bach PB
    JAMA; 2019 Apr; 321(16):1563-1564. PubMed ID: 30840047
    [No Abstract]   [Full Text] [Related]  

  • 12. Do interventions that address patient cost-sharing improve adherence to prescription drugs? A systematic review of recently published studies.
    Sensharma A; Yabroff KR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):263-277. PubMed ID: 30628493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New estimates of the demand for physical and mental health treatment.
    Meyerhoefer CD; Zuvekas SH
    Health Econ; 2010 Mar; 19(3):297-315. PubMed ID: 19350688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policy Recommendations to Promote Prescription Drug Competition: A Position Paper From the American College of Physicians.
    Daniel H; Serchen J; Cooney TG;
    Ann Intern Med; 2020 Dec; 173(12):1002-1003. PubMed ID: 32926798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of branded prescription medicine prices in OECD countries.
    Kanavos PG; Vandoros S
    Health Econ Policy Law; 2011 Jul; 6(3):337-67. PubMed ID: 21676345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Prescription Drug Spending Leading Up to Health Reform.
    Blavin F; Waidmann T; Blumberg LJ; Roth J
    Med Care Res Rev; 2014 Aug; 71(4):416-32. PubMed ID: 24830379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to Ensuring Access to Affordable Prescription Drugs.
    Mello MM
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():275-289. PubMed ID: 31136248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
    Cheng N; Banerjee T; Qian J; Hansen RA
    J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Save green, go generic: be prepared to answer the $4 question.
    Hansen D
    S D Med; 2009 Nov; 62(11):436-7. PubMed ID: 20128174
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of a price cut reform on the cost and utilization of antidiabetic drugs in Korea: a national health insurance database study.
    Suh HS; Kim JA; Lee IH
    BMC Health Serv Res; 2018 Jun; 18(1):429. PubMed ID: 29879966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.